INTRODUCTION
Hepatic bile is a complex secretion which is iso-osmotic with respect to plasma but contains a diversity of solutes whose biliary concentrations are either greater than (bilirubin, bile salts), similar to (Na+, K+, Cl-, HCOa-), or less than (phosphate, lecithin, cholesterol) their respective concentrations in plasma. Glucose is also an example of a solute that is found in bile in concentrations less than that of plasma, although variable bileplasma ratios have been reported (1) (2) (3) . Woodyatt (4) measured only negligible reducing sugars in human bile while Segato and Rosa (5) reported biliary concentrations that ranged from 25-180 mg/100 ml. Schein, Zumoff, Kream, Cassouto, and Hellman (6) found no glucose in human bile while detecting substantial amounts in bile from rat. These conflicting findings may be due in part to differences in glucose assay procedures which vary in specificity for reducing substances and sensitivity in the presence of bile, or differences in the range of plasma glucose concentrations at which the bile was assayed. Nevertheless, it is surprising that glucose is not found in bile in concentrations comparable to plasma since the bile-plasma ratios of other solutes of comparable molecular size such as mannitol or erythritol are generally very close to 1.0 (7) (8) (9) (10) (11) . Either glucose entry into bile is limited by diffusion or metabolism, or transport sites exist for removal of glucose prior to the site of bile collection.
In the present study we explored the possible mechanisms for low biliary concentrations of glucose in rat and man utilizing an enzymatic method specific for D-glucose.
METHODS

A. Animal preparation
Non-fasted male Sprague-Dawley rats, (350-400 g) were maintained on Purina Lab Chow and water ad. lib. On the day of study, they were anesthetized with i.p. nembutal (5 mg/100 g body wt), the common bile duct was cannulated with Clay-Adams PE 10 tubing (Clay-Adams, Inc., Parsippany, N. J.) and infusions of glucose were administered at various concentrations (0-25%o ) in Ringer's solutions through a no. 27 lymphangiogram needle placed in an exposed femoral vein. Infusions were maintained in all experiments at 0.06 ml/min by a Harvard no. 1100 pump (Harvard Apparatus Co., Inc., Millis, Mass.) while blood samples were obtained from an exposed jugular vein. In experiments where high plasma glucose levels were desired (greater than 250 mg/100 ml), the renal vascular pedicles were also ligated bilaterally. The temperature of each rat was maintained at 370C by heat lamp and regulated through a rectal probe by a constant temperature monitor (Yellow Springs Instrument Co., Yellow Springs, Ohio). Bile was collected at 5-15-min intervals while blood samples were removed midway during each bile collection period. The volume of removed blood approximately equaled the volume of the infusate.
B. Glucose assay procedure
A modification of the method of Sachtor and WormserShavit (12) was used, consisting of a coupled enzymatic assay in which f-D-glucopyronoside is converted to glucose-6-phosphate by Mg++-ATP dependent hexokinase. Glucose-6-PO4 is then converted to 6-phosphogluconolactone by the enzyme glucose-6-PO4 dehydrogenase, reducing NADP to NADPH, which is measured spectrophotometrically at 340 nm. The method is specific for 8-D-glucopyronoside and is sensitive to 1 mg/100 ml in rat bile and 3 mg/100 ml in human bile.
The assay system consisted of: (a) 0.10 ml of a reaction mixture comprised of 48 mg NADP, 2.5 ml of 0.5 M KHPO4 at pH 7.6; 0.6 ml 0.1 M disodium ATP (Sigma Chemical Co., St. Louis, Mo.) at pH 7.0; and 0.6 ml 0.1 M MgCI2, all diluted to a total volume of 10 ml; (b) 0.01 ml hexokinase (Sigma Chemical Co.) diluted 1:10 in 400 mg/ 100 ml solution bovine albumin; (c) 0.01 ml glucose-6-PO4 dehydrogenase (Sigma Chemical Co.) diluted 1: 5 in 400 mg/100 ml solutions of bovine albumin; (d) a 0.01 ml-0.05 ml sample of plasma, bile, or liver cell supernate; (e) and sufficient water to equal a total volume of 0.62 ml in a 1.0 ml cuvette. Plasma or bile samples (usually 0.1 ml) were diluted 1:10-1: 20 in water so that the amount of glucose in each cuvette varied between 0.01 and 1.0
Amol. Initial readings of optical density were made in a Zeiss PMQ II spectrophotometer (Carl Zeiss, Inc., New York) at 340 nm and 250C, before adding hexokinase. A reagent blank, in which water was substituted for sample, was also obtained. Hexokinase was then added and the resulting production of NADPH was measured by subtracting the final from initial optical density (OD) after correcting for absorbance in the blank (usually 0.003 OD). Since the molar extinction coefficient for NADPH is 6.22 X 106 cm' the OD * 10 gave the total micromoles glucose in each sample. Dividing this value by the sample volume gave the glucose concentrations which was expressed in milligrams per 100 milliliter. Bile volume was measured in a tuberculin syringe. The bile and plasma samples were usually assayed directly but could be frozen for 5-10 days without loss of activity.
Assay of glucose standards gave the expected values within 5% on repeated determinations whether added to bile or to water. The addition of decholin, xylose, and amethyl glucose had no effect on the assay. Phlorizin increased the initial OD but did not alter the recovery of glucose standards. As a further control, 0.024 ,umol of glucose standard was added to each cuvette after the final OD had been determined and the increase in absorbance measured to assure that inhibitors were not present and that the reactants were in excess.
Plasma glucose values increased or decreased slowly in a linear fashion during experimental periods, changing by less than 15% and the mean plasma value for a given bile collection period was extrapolated from a linear plot of plasma concentrations. Bile flow was then allowed to resume by lowering the cannula to its former level. Spontaneous flow resumed immediately and 20 subsequent drops were collected in separate vials of dioxane. The 3H/"C ratios in bile were subsequently determined by counting in a Nuclear-Chicago Isocap 300 liquid scintillation counter (Nuclear-ChicagoCorp., Des Plaines, Ill.) with quenching determined by external standard ratios. Plasma samples were obtained at the end of the stop-flow period and at the termination of the study when samples of liver were also removed for determination of liver-plasma ratios of both [3H] (14) and the bile glucose curve was adjusted accordingly with reference to the plasma curve.
RESULTS
A. Animal studies Plasma-bile glucose titration curve. (a) Fig. 1 shows the bile glucose concentrations over a range of plasma glucose up to 900 mg/100 ml. At normal plasma levels (80-100 mg/100 ml) and prior to glucose infusion, some glucose was present in the bile but at much lower concentrations than would be observed if bile/plasma glucose ratios were 1.0. As the plasma glucose levels increased to 400 mg/100 ml (group A) the bile glucose concentration increased but only to a small extent. The slope of the regression line for these points (line A) was 0.22 by the method of least squares. However, as the plasma glucose rose from 400 to 900 mg/100 ml (group B) the bile glucose concentration increased at a rate three times greater than in group A, and the slope of the regression line was 0.68 (line B). If PLASMA GLUCOSE mg/l1oml FIGURE 1 Plasma-bile glucose titration curve (milligrams per 100 ml). Line A represents the regression for values of plasma glucose ranging from 0 to 300 mg/100 ml (group A) while line B represents the regression for plasma glucose values between 400 and 900 mg/ 100 ml (group B). The dotted line with a slope of 1 represents the theoretical regression for solutes such as mannitol or erythritol. The data is obtained from 1 to 4 collection periods in 24 separate experiments.
mannitol achieved bile-plasma ratios of approximately one. Despite similarity in molecular size and liver-plasma ratios that also approximated 1.0, 3-0-methyl glucose, behaved like glucose and achieved significantly lower concentrations in bile resulting in bile-plasma ratios that averaged 0.30±0.05 (Table I) .
Liver glucose. In five control experiments and three with phlorizin, simultaneous glucose concentrations in plasma, bile, and liver water indicated that glucose concentration in liver water was substantially greater in each instance than the corresponding plasma value (13) (Table II) . Since plasma and liver water glucose concentration paralleled each other over a ninefold range in plasma glucose, glucose entry into the hepatocyte was not limiting in these experiments. Furthermore, (Table I) , liver-plasma ratios of the glucose analogue, [3-14C] 0-methyl glucose, were close to one, suggesting that these sugars are not limited in their entry into hepatic water.
Competative inhibitors. Phlorizin caused a marked increase in bile glucose concentration when injected slowly into the portal vein, although plasma levels did not change significantly. Fig. 3 shows that the increase in bile glucose varied from 2 to 10 times that of the preinjection level. Bile glucose remained relatively constant during this time if phlorizin was not injected. Contrary Glucose concentration in milligrams per 100 ml in plasma, liver, and bile in five control rats (1) (2) (3) (4) (5) and three treated with phlorizin (6-8). * Milligrams glucose per 100 ml intracellular water.
Pre-phlorizin value given in parenthesis.
to findings in dogs, phlorizin had no effect on bile flow in these studies.
The portal vein infusion of a-MG resulted in a twoto fourfold increase in bile glucose concentrations in two experiments with similar but not as large effects as phlorizin. In contrast, when xylose was infused in one study no change in bile glucose concentrations occurred. Portal vein and jugular vein glucose concentrations were essentially equal when sampled simultaneously during the infusion. Biliary glucose excretion as a function of the estimated secreted glucose load. Assuming that glucose concentrations in canalicular bile initially equaled plasma concentrations, estimates of the secreted load of glucose (plasma glucose concentration X bile volume) are shiown in Fig. 4 Fig. 1 . When estimates of hepatic glucose excretion were correlated with biliary glucose excretion over a wide range in plasma glucose concentration, biliary glucose excretion increased in a linear fashion identical to the control observations obtained at lower flow rates. (Fig. 5) . slowly in a retrograde fashion into the biliary tree through the PE 10 cannula and bile flow was temporarily stopped for 5 min (Fig. 6) .
B. Human experiments
Patient no. 1 was studied 6 wk after cholecystectomy and common duct exploration at a time when routine liver function tests were normal. There was no history of diabetes and an i.v. glucose tolerance test was normal. During the control period bile glucose could hardly be detected at plasma glucose levels of 90 mg/100 ml. The effect of dehydrocholate on biliary glucose excretion in four studies obtained at-plasma glucose concentrations ranging from 300 to 1,250 mg/100 ml. The regression line (y = -38.3 + 0.65 x) had a correlation coefficient of 0.99, P < 0.001, and was nearly identical to line B in Fig. 4, represented (8) . These solutes appear to equilibrate rapidly in hepatocyte water within minutes (16) and enter bile at that level rather than through or between bile ductular cells. Therefore, glucose which is similar in molecular size might also be expected to enter bile in similar concentrations and its markedly diminished concentration in bile is unexplained, although several possibilites could account for this phenomenon.
First, glucose entry into the hepatocyte might be limited. Secondly, glucose entering the liver might be rapidly metabolized, converted to glycogen or otherwise consumed so that a reduced amount is available for diffusion into bile. Third, there could be a selective barrier for glucose entry from the hepatocyte into bile which is less effective at higher glucose concentrations.
Fourth, glucose might enter the canalicular bile in equal concentration to liver cell water and plasma and subsequently be removed from bile by active transport at some site along the biliary system. If glucose load exceeded the capacity for reabsorption, its concentration would increase in collected bile in a manner analogous to the mechanism of renal glycosuria. Finally, water alone might be secreted at the ductular level causing dilution of bile and diminished glucose concentration. This last possibility may be excluded in the rat since ductular secretion is minimal and other nontransportable, nonmetabolized solutes such as mannitol would be expected to be diluted as well, and this does not occur (10) .
Considering the possibility of limited hepatic glucose entry or increased hepatic glucose consumption, Cahill, Earle, and Zotta have shown that glucose freely enters the liver and that glucose concentrations in rat hepatic water are roughly comparable to those in the plasma over a range in plasma concentration (17) . Our own studies were similar except that hepatic glucose concentrations were somewhat higher than plasma. It is possible that gluconeogenesis or glycogen degradation to glucose might have occurred during the boiling procedure for hepatic glucose extraction. However, our technique did not reveal higher values for hepatic glucose in normal rats when compared with Cahill's method. Our animals were not fasted, however, so that it is possible that some glycogenolysis did occur. Nevertheless, the ratio of liver to plasma glucose remained fairly constant despite a 10-fold change in plasma glucose concentrations so that glucose must be available for entry into the hepatocyte over the range of plasma glucose used in this study. We can assume, therefore, on the basis of Cahill's studies and our own, that glucose should be present in liver cell water in amounts at least equal to, if not greater than that observed in plasma.
If we assume that glucose can enter bile, presumably by diffusion and solvent drag, as is the case for solutes like mannitol (9) , then biliary glucose excretion may be represented as a function of the estimated secreted hepatic load. If glucose enters bile in concentrations that are equal to plasma, as shown in Fig. 4 , no significant relationship is observed between load and excretion until the glucose load exceeds 50 ig/min. Thereafter, a progressive increase in biliary glucose excretion is observed for every increment in hepatic glucose secretion, a phenomenon which suggests a threshold for biliary glucose reabsorption.
Should glucose enter bile in lower concentrations than estimated, then glucose must be restricted in diffusion from the hepatocyte, unlike mannitol, a carbohydrate of similar size. In this case, dehvdrocholate in-duced canalicular secretion might be expected to lower the bile-plasma glucose concentration ratios. This did not occur. Rather, bile-plasma glucose concentration ratios remained essentially unchanged from the control titration curve observed in Fig. 1 , and glucose clearance was increased proportionately to the canalicular choleresis that occurred when dehydrocholate was infused. However, bile flow diminishes as plasma glucose rises and if this hyperglycemic anticholeresis (Fig. 2) is produced by osmotic effects at the canaliculus, then glucose could not be in diffusion equilibrium between liver cell water and bile since the concentration of glucose in hepatocyte must be increasingly larger than bile as bile flow diminishes. Should this occur, our figures for hepatic glucose excretion and thus biliary glucose reabsorption would be progressively overestimated as plasma glucose concentrations increased. It is difficult to reconcile this possibility however with the failure of dehydrocholate choleresis to diminish bile-plasma glucose ratios, as discussed above. Alternatively, hyperosmolar glucose might have a toxic effect on hepatocyte bile secretion as Brauer has suggested to explain why i.v. hyperosmolar sodium chloride diminishes bile flow in the rat (18) .
Could glucose entry into bile be larger than estimated? This is possible, particularly since liver cell glucose concentrations appeared to be higher than concentrations in plasma (Table II) . Also, canalicular flow might be greater than total flow if water is reabsorbed from bile at the duct level as plasma glucose concentrations increase. Both of these possibilies would result in a larger than estimated secreted load of glucose, thereby lowering the slope of line B in Fig. 4 , and indicating that the ductular capacity to reabsorb glucose was actually larger than suggested by the present estimates. It seems unlikely, however, that bile flow was diminished by reabsorption of water at the bile duct level during hyperosmolar anticholeresis (Fig. 2) , since Chenderovitch's studies with hyperosmotic mannitol in the rabbit (19) indicate that the effects of osmotic anticholeresis occur proximally at the level of the hepatocyte rather than distally at the ducts. Furthermore, in our own studies in the rat, bile-plasma ratios of ["4C]erythritol were increased by only 3±-3.7% when total bile flow was reduced by 52±4.6% during hyperglycemia in four experiments suggesting that hyperglycemic anticholeresis appears to predominantly affect canalicular flow in the rat as well.
That the increasing appearance of glucose in bile is not related to the rate of bile flow per se can be deduced from a comparison of line B in Fig. 4 and the post-dehydrocholate data (Fig. 5) . Biliary glucose excretion is identical at a given glucose load irrespective of whether the load is produced by high plasma glucose concentrations and low bile flow rates (Fig. 2) or at low plasma glucose concentrations but high post-dehydrocholate flow rates. The determinants of biliary glucose excretion, therefore, seem to be the magnitude of the glucose load irrespective of the rate of canalicular bile secretion.
These considerations leave us with the final possibility; namely, that glucose must be transported out of bile at some point during passage from the hepatocyte to the biliary cannula, a conclusion which can be strengthened by several additional findings.
As already indicated, the pattern of the bile-glucose titration curves (Figs. 1 and 4) suggest a transport system which results in an increase of glucose in bile when the biliary ductules are presented with an increase in substrate load.
The studies with classic inhibitors of glucose transport (Figs. 3 and 4) provide further support for a biliary glucose transport system since phlorizin is known to cause reversible inhibition of active transport of glucose in the intestine and kidney (20) . Since phlorizin neither inhibits glucose entry into liver cells (21) nor lowers the hepatic.concentration of glucose in the present study, and since phlorizin entered bile (as indicated by a rise in blank values in the glucose assay, and as previously shown by Jenner and Smyth for the dog) (22) it is likely that the rise in biliary glucose excretion was secondary to inhibition of glucose reabsorption from bile. An increase in bile glucose has also been observed in dog bile after phlorizin (23) . Another competitive inhibitor of glucose transport in the intestine, a-methyl-d-glucopyronoside, also increased the bile glucose concentration without resulting in a parallel rise in plasma glucose concentration while xylose, which has no effect on intestinal glucose transport, did not (24) . Since amethyl-d-glucopyronoside freely penetrates liver cells (17) and is not metabolized, it also could have competitively inhibited glucose reabsorption from bile. It was necessary to inject both phlorizin and a-methyl-dglucopyronoside into the portal vein in order to demonstrate increases in bile glucose suggesting that dilution in peripheral blood negated any effect of these compounds on biliary glucose transport.
Finally, results from the stop-flow experiments are also consistent with the glucose reabsorption hypothesis since they demonstrate that both glucose and 3-0-methyl glucose are selectively removed from bile during periods of stop flow when compared with mannitol, a sugar of comparable size. 3-0-methyl glucose, like glucose, is present in bile in concentrations that are considerably less than mannitol during free flow of bile and diminish further when bile is temporarily stopped. Selective reabsorption of either glucose or 3-0-methyl glucose also occurred if these solutes were injected with mannitol in a retrograde fashion into the biliary tree (Fig. 6) . Because all these experimental approaches suggested the existence of a biliary transport system for both glucose and 3-0-methyl glucose, this system should be analagous to tubular transport mechanisms for glucose in the kidney. If this were so, then biliary reabsorption of glucose must be a function of the hepatic excretion of glucose much in the manner that tubular reabsorption of glucose in the kidney is a function of the filtered load at the glomerulus. This relationship could be expressed mathematically again assuming that bile glucose levels were initially comparable to plasma levels prior to reabsorption of glucose from bile. Then: bile glucose reabsorption (BGR) = hepatic glucose excretion (bile flow X plasma glucose concentration) -(bile glucose concentration X bile flow). This function is represented in Fig. 8 and describes an hyperbola suggesting that glucose transport in the rat biliary tree obeys Michaelis
